ArticleCell reports. Medicine2024

Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia.

Guillermo Montalban-Bravo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.